DE68926245T2 - Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten - Google Patents

Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten

Info

Publication number
DE68926245T2
DE68926245T2 DE68926245T DE68926245T DE68926245T2 DE 68926245 T2 DE68926245 T2 DE 68926245T2 DE 68926245 T DE68926245 T DE 68926245T DE 68926245 T DE68926245 T DE 68926245T DE 68926245 T2 DE68926245 T2 DE 68926245T2
Authority
DE
Germany
Prior art keywords
diagnosis
cancer
diseases
detection
base membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926245T
Other languages
English (en)
Other versions
DE68926245D1 (de
Inventor
Aken Morgan Van
Stefan Paskell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Diagnostic Sciences Inc
Original Assignee
Bard Diagnostic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Diagnostic Sciences Inc filed Critical Bard Diagnostic Sciences Inc
Publication of DE68926245D1 publication Critical patent/DE68926245D1/de
Application granted granted Critical
Publication of DE68926245T2 publication Critical patent/DE68926245T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68926245T 1988-12-12 1989-12-11 Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten Expired - Fee Related DE68926245T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28339788A 1988-12-12 1988-12-12
PCT/US1989/005534 WO1990007116A1 (en) 1988-12-12 1989-12-11 Detection of basement membrane components as diagnostic of cancer and other diseases

Publications (2)

Publication Number Publication Date
DE68926245D1 DE68926245D1 (de) 1996-05-15
DE68926245T2 true DE68926245T2 (de) 1996-08-22

Family

ID=23085870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926245T Expired - Fee Related DE68926245T2 (de) 1988-12-12 1989-12-11 Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten

Country Status (7)

Country Link
EP (2) EP0447490B1 (de)
JP (1) JPH04502363A (de)
AU (1) AU4845390A (de)
CA (1) CA2005190A1 (de)
DE (1) DE68926245T2 (de)
ES (1) ES2085346T3 (de)
WO (1) WO1990007116A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
AU665764B2 (en) * 1991-05-29 1996-01-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
CA2125769C (en) * 1991-12-13 1999-01-26 Morgan Van Aken Agglutination assays and kits employing colloidal dyes
DE69414393D1 (de) * 1993-07-23 1998-12-10 Bard Diagnostic Sciences Inc Verfahren zur bestimmung der invasivität eines blasentumors
JPH08100000A (ja) * 1994-09-30 1996-04-16 Morinaga & Co Ltd ヒトｉｖ型コラーゲンに対する抗体及びその利用
AU3728595A (en) * 1994-10-18 1996-05-06 Amdl, Inc. Antibodies against an extracellular matrix complex and their use in the detection of cancer
JP5754844B2 (ja) * 2010-03-09 2015-07-29 国立大学法人 東京大学 泌尿器科がんの検査方法及び検査用キット

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923583A1 (de) * 1979-06-11 1980-12-18 Max Planck Gesellschaft Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
JPS59212768A (ja) * 1983-05-18 1984-12-01 Green Cross Corp:The 人胎盤由来基底膜関連蛋白質ｂｍａｐ測定用試薬
DE3410049A1 (de) * 1984-03-19 1985-09-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung der globulaeren domaene von basalmembrankollagen und immunologische bestimmung von basalmembranmaterial und autoantikoerpern
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
FR2606034B1 (fr) * 1986-10-31 1989-06-02 Cird Nouvelle proteine de surface des cellules basales de l'epiderme, anticorps capables de reconnaitre cette proteine, et leur utilisation, et lignees cellulaires hybrides capables de secreter de tels anticorps
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex

Also Published As

Publication number Publication date
EP0664453A1 (de) 1995-07-26
ES2085346T3 (es) 1996-06-01
JPH04502363A (ja) 1992-04-23
EP0447490B1 (de) 1996-04-10
EP0447490A1 (de) 1991-09-25
DE68926245D1 (de) 1996-05-15
WO1990007116A1 (en) 1990-06-28
CA2005190A1 (en) 1990-06-12
AU4845390A (en) 1990-07-10

Similar Documents

Publication Publication Date Title
DE3771185D1 (de) Optischer detektor zur gleichzeitigen erfassung von herzschlag und toraxbewegung.
DE69016784T2 (de) Filterplatte, filterplattenelement und filter, der dieselben enthält.
DE3786054T2 (de) Mikrofuehler.
NO901158D0 (no) Blodtrykk-overvaakningskateter.
MX3173A (es) Complejos de flavanolignanos/fosfolipidos y procedimiento de obtencion.
FI905177A0 (fi) Foerfarande foer framstaellning av antibakteriella formade produkter av polyolefinharts.
DE69012053T2 (de) Dichtung und Dichtungsaufbau.
DK1091D0 (da) Immunkonjugater til diagnose og behandling af cancer
DE3750432D1 (de) IL-1 alpha Derivate und Medikamente.
DE68914743T2 (de) Blutprobenröhrchen.
DE68911975D1 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
DE3869489D1 (de) Erhoehte chemilumineszierende reaktion und diagnostischer test.
DE3784667D1 (de) Transkutaner blutgasmessfuehler.
DE68926245D1 (de) Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
NO882978L (no) Innretning for leverfunksjonsproeving.
DE68911974D1 (de) Ophthalmologisches Diagnose-Verfahren und Gerät.
NO904898D0 (no) Baaren filtreringsmembran og fremgangsmaate for fremstilling av denne.
NO882950D0 (no) Diagnostisk test for stafylokokk-foraarsaket mastitt.
NO883626L (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
DE3872790T2 (de) Geraet zur untersuchung von reissverschlusselementen.
DE3886032D1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DE69017807T2 (de) Dichtelement und Baueinheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee